Introduction
I.
Non-Prescription Medication Policy
II.
Unapproved Use of Formulary
Medication
III.
Prior Authorization Procedure
IV.
Unique Patient Needs Non-Formulary
Medication
V.
Newly Marketed Products
VI.
Specific Exclusions
VII.
Policy for Injectable Drugs
VIII.
Dispensing Limits
IX.
Mandatory Generic Substitution
X.
DESI Drug Explanation
XI.
Health Industry Numbers
XII.
Where to Call
XIII.
TLC Phone Numbers for Member
Services
XIV.
TLC Contacts for Medical Appeals
XV.
Annotations
This formulary describes the
circumstances under which pharmacies participating in a particular medical
benefit program will be reimbursed for medications dispensed to patients
covered by the program. This formulary
does not:
a) Require or prohibit the prescribing or dispensing of any
medication.
b) Substitute for the independent professional judgment of
the physician or pharmacist or
c) Relieve the physician or pharmacist of any obligation to
the patient or others.
The TLC program does not cover
most over-the-counter medications (OTC).
The only exceptions to this policy are listed in this booklet. Furthermore, an OTC medication can be reimbursed
only if it is written on a valid prescription form by a licensed prescriber.
II. Unapproved Use of Formulary Medication
Medication coverage under this
program is limited to non-experimental indications as approved by the FDA. Other indications may also be covered if
they are accepted as safe and effective by the balance of current medical
opinion and available scientific evidence.
Reimbursement decisions for these other indications will be made by
Scrip Pharmacy Solutions in accordance with the procedures outlined in section
IV. Experimental, investigational drugs
and drugs used for cosmetic purposes are not eligible for coverage.
III. Prior Authorization
Procedure
Prior authorization procedures are
used to promote appropriate utilization of selected high risk and/or high cost
medication. The Scrip Pharmacy Solutions/TLC program has established the
criteria for this system with input from pharmacist and physician practitioners
and in consideration of medical literature.
The Pharmacy and Therapeutics Committee will have final approval
responsibility for the list of drugs that are subject to prior
authorization.
In order for a dispensed prior
authorization medication to be reimbursed to the pharmacy, the patient's
prescribing physician must apply for pre-authorization for a specific patient
and drug. The physician may phone or
fax Scrip Pharmacy Solutions to request prior authorization:
Scrip
Pharmacy Solutions
Prior Authorization Desk
33 North Road
Wakefield, RI 02879-2164
(800) 762-2299 (phone)
(800) 354-5979 (fax)
Please have patient information, including social security
number, complete diagnosis, medication history and current medications readily
available.
These phone lines are dedicated to
physicians making requests for prior authorization medication items only.
Subscribers cannot be assisted if they call the prior-authorization toll-free
number. All faxed approval requests
will be responded to within twenty-four (24) hours during the business week and
within seventy-two (72) hours on weekends and holidays. If the request is approved, information in
the on-line pharmacy claims processing system will be changed to allow the
specific patient to receive this specific drug. A prior authorization number will be issued to the prescribing
physician and is to be clearly written on the top of the prescription to inform
the dispensing pharmacist of the approval.
This number is for identification purposes only and does not need to be
submitted for adjudication to occur. If
the request is denied, information about the denial will be provided to the
physician.
Medications requiring prior
authorization are listed with a prior approval notation throughout the
formulary. The index also includes a
"PA" designation for those products requiring prior authorization. In addition, all injectables (except
insulin, Glucagon Kit, Epi-pen, Ana-Kit, and Depo-Provera) require prior
authorization.
IV. Unique Patient Needs Non-Formulary
Medication
This formulary
attempts to provide appropriate and cost effective drug therapy to all
participants in the Scrip Pharmacy Solutions/TLC program. If a patient requires medication that is not
covered by the formulary, the physician can make a request for payment for the
non-covered item. It is anticipated
that such exceptions will be rare, and that formulary medications will be
appropriate to treat the vast majority of medical conditions. Requests for these exceptions should be made
in writing by the physician (on the "request for non-formulary medication form"
if possible) and mailed or faxed to:
Scrip Pharmacy Solutions
Medical Necessity Desk
33 North Road
Wakefield, RI 02879-2164
(800) 354-5979
Appropriate
documentation must be provided to support the request. A response will be provided within one- (1)
business day of receipt of this information.
Approval of non-formulary items will be based upon criteria developed by
the Pharmacy and Therapeutics Committee of Scrip Pharmacy Solutions/TLC.
Physicians are expected to comply
with this formulary when prescribing medication for those patients covered by
the Scrip Pharmacy Solutions/TLC plan.
If a pharmacist receives a prescription for a non-formulary medication,
the pharmacist should attempt to contact the prescribing physician to request a
change to a product included in this formulary guide.
The pharmacy will not be
reimbursed for non-formulary medications.
In an emergency situation outside Scrip Pharmacy
Solutions regular business hours, where the physician cannot be contacted, the
pharmacist is authorized to dispense a 72 hour emergency supply of a
medication, unless the medication is classified as a DESI, LTE or specifically
excluded drug category (see section VI) product. The
pharmacist should contact Scrip Pharmacy Solutions Customer Service line at
(800) 213-5640 during regular business hours to arrange for reimbursement for
the emergency supply.
V. Newly Marketed Products
Newly marketed drug products will
not normally be placed on the formulary during their first year on the
market. Exceptions to this rule will be
made on a case by case basis using the medical necessity procedure.
VI.
Specific Exclusions
The following drug categories are
not part of the Scrip Pharmacy Solutions/TLC formulary and are not covered by the 72 hour emergency supply reimbursement policy:
Research drugs
Medical
supplies and durable medical equipment (except those listed in formulary)
Injectables
(except for in-home use administered by patient)
Cough and
cold products (except those listed in formulary)
Biologicals
Blood and
blood plasma
DESI
drugs (see section XI)
Nutritional
and dietary supplements
Most
vitamins
Antiobesity
products
Topical
minoxidil
Anti-acne
products
Diagnostic
products (except those listed in formulary)
Cosmetic
drugs
Norplant
Smoking
Cessation products
Fertility
Drugs
Fluoride
Rinses
OTC Medications (see section I)
Sexual
Dysfunction products
VII.
Policy for Injectable Drugs
Injections that are
self-administered by the patient and/or a family member and are listed within
the program formulary are covered on the Scrip Pharmacy Solutions/TLC
program. Scrip Pharmacy Solutions does
not cover injections given in the doctors' office or home health. Any questions regarding this policy should
be directed to TLC at the following number:(800)
473-6523
VIII.
Dispensing Limits
All drugs may be dispensed in a
30-day supply with a maximum of 400 units.
Seventy-five percent (75%) of the days' supply must elapse before the
prescription can be refilled. (A
prescription can be refilled at 22 days.)
The following are exceptions:
|
DRUG |
DISPENSING LIMITATIONS
|
|
|
|
|
Acetest
Reagent |
Max qty
100 per prescription fill |
|
Aerobid-M,
Aerobid |
Max qty
21gms and/or a min days supply of 10 |
|
Albuterol |
Max qty
85gms and/or a min days supply of 6 |
|
Alcohol
Pads & Glucometer Strips |
Max qty
200 per prescription fill |
|
Alupent |
Max qty
70gms and/or a min days supply of 6 |
|
Atrovent |
Max qty
70gms and/or a min days supply of 6 |
|
Azmacort |
Max qty
100gms and/or a min days supply of 6 |
|
Betaseron |
Max qty
15 per prescription fill |
|
Clinitest
Reagent |
Max qty
36 per prescription fill |
|
Clonidine |
Covered
for patients greater than 18 years |
|
Glucometers |
Max qty
1 per 365 days |
|
Imitrex
25mg |
Max qty
18 per 30 days |
|
Imitrex
Inj. Kit |
Max qty
3 per prescription fill |
|
Imitrex
nasal spray |
Max qty
1 box per 30 days |
|
Lorabid
Suspension |
Limited
to patients 12 years and younger |
|
Maxair
& Maxair Autoinhaler |
Max qty
70gms and/or a min days supply of 6 |
|
Analgesic
narcotics containing |
|
|
Parlodel |
Limited
to women 45 years and older (no limit on men) |
|
Serevent |
Max qty
26gms and/or a min days supply of 30 |
|
Stadol
NS |
Max qty
3 per 30 days |
|
Test
Strips |
Max qty
200 per 30 days |
|
Tilade |
Max qty
81gms and/or a min days supply of 6 |
|
Urine
Glucose Test Kit |
Max qty
1 per prescription fill |
|
Vanceril |
Max qty
85gms and/or a min days supply of 6 |
|
Zovirax |
Limited
to patients 15 years and older |
|
|
Ointment - initial episode only |
IX.
Mandatory
Generic Substitution
Generic substitution is mandatory
when a generic equivalent is available.
All branded products that have 3 or more A-rated generic equivalents
will be reimbursed at the maximum allowable cost. The mandatory generic substitution provision is waived for the
following four products due to their narrow therapeutic index: Coumadin,
Dilantin, Lanoxin, and Theodur.
X.
DESI
Drug Explanation
DESI
drugs are an exclusion for the Scrip Pharmacy Solutions/TLC program.
DESI drug products and known
related drug products are defined as less than effective by the Food and Drug
Administration because there is lack of substantial evidence of effectiveness
for all labeling indications and because a compelling justification for their
medical need has not been established.
The Health Care Finance Administration (HCFA) does not allow for
reimbursement of these drugs.
72-hour emergency supply of medication for this member. If Scrip Pharmacy Solutions is unable to locate a Medicare provider in your area, or if the member has a transportation problem, an override will be placed in the appropriate claims processing system, which will allow reimbursement for one month of medication for this member.
XI. Health Industry Numbers
TLC utilizes Health Industry
Numbers (HIN) for the pharmacy network. For all TLC Prescriptions, please use
valid HIN numbers only. For
prescriptions without HIN numbers, please call Scrip Pharmacy Solutions at 1-800-230-8189.
XII. Where to Call
PHYSICIANS
Formulary Questions:
Scrip Pharmacy Solutions (800)
762-2299
Medical Necessity:
Scrip Pharmacy Solutions (800)
762-2299
Prior Authorization:
Scrip Pharmacy Solutions (800)
762-2299
PHARMACISTS
Provider Network Questions:
Scrip Pharmacy Solutions (800)
230-8187
Claims Processing Customer
Service:
Scrip Pharmacy Solutions (800)
213-5640
SUBSCRIBERS
Subscriber Questions:
Should be directed to the
subscriber's MCO or Physician.
XIII. TLC
Phone Numbers for Member Services
TLC Family Care Health Plan (800)
473-6523
XIV. TLC
Contacts for Medical Appeals
In the event
that a patient and/or physician disagrees with the decision regarding coverage
of a medication, the physician may appeal the decision in writing to the
Clinical Coordinator at Scrip Pharmacy Solutions via fax at (800)
354-5979. In the event that the patient
and/or physician disagrees with the decision of the Clinical Coordinator, the
physician may then appeal this decision in writing to Marilyn Lee, Pharm D., Pharmacy Director at the following
address and fax:
TLC
Regional Medical Center
877 Jefferson Street
Memphis, TN 38103
FAX (901) 545-7351
XV. Annotations
| Excl. | = This product is an exclusion for the plan listed. |
| Only | = This product is formulary only for the plan listed. |
| PA | = This product requires prior authorization for the plan listed. |
| * | = This product has a MAC price attached to some or all strengths. |
| $ | = Cost per Rx is <$20 |
| $$ | = Cost per Rx is <$40 |
| $$$ | = Cost per Rx is $40 - $80 |
| $$$$ | = Cost per Rx is $80 - $160 |
| $$$$$ | = Cost per Rx is >$160 |
|
Introduction Therapeutic Formulary Prior Authorization Guidelines |
|
|
||
|
|